545 related articles for article (PubMed ID: 25476900)
1. Koschei the immortal and anti-aging drugs.
Blagosklonny MV
Cell Death Dis; 2014 Dec; 5(12):e1552. PubMed ID: 25476900
[TBL] [Abstract][Full Text] [Related]
2. From rapalogs to anti-aging formula.
Blagosklonny MV
Oncotarget; 2017 May; 8(22):35492-35507. PubMed ID: 28548953
[TBL] [Abstract][Full Text] [Related]
3. Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to.
Blagosklonny MV
Aging (Albany NY); 2012 May; 4(5):350-8. PubMed ID: 22683661
[TBL] [Abstract][Full Text] [Related]
4. The use of calorie restriction mimetics to study aging.
Kitada M; Koya D
Methods Mol Biol; 2013; 1048():95-107. PubMed ID: 23929100
[TBL] [Abstract][Full Text] [Related]
5. Dissecting mammalian target of rapamycin to promote longevity.
Mendelsohn AR; Larrick JW
Rejuvenation Res; 2012 Jun; 15(3):334-7. PubMed ID: 22758368
[TBL] [Abstract][Full Text] [Related]
6. Aging and TOR: interwoven in the fabric of life.
Sharp ZD
Cell Mol Life Sci; 2011 Feb; 68(4):587-97. PubMed ID: 20960025
[TBL] [Abstract][Full Text] [Related]
7. An anti-aging drug today: from senescence-promoting genes to anti-aging pill.
Blagosklonny MV
Drug Discov Today; 2007 Mar; 12(5-6):218-24. PubMed ID: 17331886
[TBL] [Abstract][Full Text] [Related]
8. TOR-inhibitors as gero-suppressors.
Nikiforov M
Aging (Albany NY); 2015 Dec; 7(12):1030-1. PubMed ID: 26796970
[No Abstract] [Full Text] [Related]
9. Lifespan-extending caloric restriction or mTOR inhibition impair adaptive immunity of old mice by distinct mechanisms.
Goldberg EL; Romero-Aleshire MJ; Renkema KR; Ventevogel MS; Chew WM; Uhrlaub JL; Smithey MJ; Limesand KH; Sempowski GD; Brooks HL; Nikolich-Žugich J
Aging Cell; 2015 Feb; 14(1):130-8. PubMed ID: 25424641
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II blockade: how its molecular targets may signal to mitochondria and slow aging. Coincidences with calorie restriction and mTOR inhibition.
de Cavanagh EM; Inserra F; Ferder L
Am J Physiol Heart Circ Physiol; 2015 Jul; 309(1):H15-44. PubMed ID: 25934099
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin extends life- and health span because it slows aging.
Blagosklonny MV
Aging (Albany NY); 2013 Aug; 5(8):592-8. PubMed ID: 23934728
[TBL] [Abstract][Full Text] [Related]
12. Short-term treatment with rapamycin and dietary restriction have overlapping and distinctive effects in young mice.
Fok WC; Zhang Y; Salmon AB; Bhattacharya A; Gunda R; Jones D; Ward W; Fisher K; Richardson A; Pérez VI
J Gerontol A Biol Sci Med Sci; 2013 Feb; 68(2):108-16. PubMed ID: 22570137
[TBL] [Abstract][Full Text] [Related]
13. Rapalogs and mTOR inhibitors as anti-aging therapeutics.
Lamming DW; Ye L; Sabatini DM; Baur JA
J Clin Invest; 2013 Mar; 123(3):980-9. PubMed ID: 23454761
[TBL] [Abstract][Full Text] [Related]
14. Subacute calorie restriction and rapamycin discordantly alter mouse liver proteome homeostasis and reverse aging effects.
Karunadharma PP; Basisty N; Dai DF; Chiao YA; Quarles EK; Hsieh EJ; Crispin D; Bielas JH; Ericson NG; Beyer RP; MacKay VL; MacCoss MJ; Rabinovitch PS
Aging Cell; 2015 Aug; 14(4):547-57. PubMed ID: 25807975
[TBL] [Abstract][Full Text] [Related]
15. Is Rapamycin a Dietary Restriction Mimetic?
Unnikrishnan A; Kurup K; Salmon AB; Richardson A
J Gerontol A Biol Sci Med Sci; 2020 Jan; 75(1):4-13. PubMed ID: 30854544
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction.
Miller RA; Harrison DE; Astle CM; Fernandez E; Flurkey K; Han M; Javors MA; Li X; Nadon NL; Nelson JF; Pletcher S; Salmon AB; Sharp ZD; Van Roekel S; Winkleman L; Strong R
Aging Cell; 2014 Jun; 13(3):468-77. PubMed ID: 24341993
[TBL] [Abstract][Full Text] [Related]
17. The role of the TOR pathway in mediating the link between nutrition and longevity.
Lushchak O; Strilbytska O; Piskovatska V; Storey KB; Koliada A; Vaiserman A
Mech Ageing Dev; 2017 Jun; 164():127-138. PubMed ID: 28315697
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin, anti-aging, and avoiding the fate of Tithonus.
Richardson A
J Clin Invest; 2013 Aug; 123(8):3204-6. PubMed ID: 24063054
[TBL] [Abstract][Full Text] [Related]
19. Interventions: Live long and prosper.
Bourzac K
Nature; 2012 Dec; 492(7427):S18-20. PubMed ID: 23222670
[No Abstract] [Full Text] [Related]
20. mTOR, glycotoxins and the parallel universe.
Green AS
Aging (Albany NY); 2018 Dec; 10(12):3654-3656. PubMed ID: 30540565
[No Abstract] [Full Text] [Related]
[Next] [New Search]
